Hexagon Bio Stock

hexagonbio.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $184.68MM

Hexagon Bio is a developer of a data-driven synthetic biotech platform that analyzes microbial genomes to develop new medicines.

Register for Details

For more details on financing and valuation for Hexagon Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Hexagon Bio.

Register Today

Other companies like Hexagon Bio in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$1.33B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$405.17MM
Updated on: Oct 4, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.